125 related articles for article (PubMed ID: 22433834)
1. Association between KLK3 rs2735839 G/A polymorphism and serum PSA levels in Japanese men.
Nobata S; Hishida A; Naito M; Asai Y; Mori A; Kuwabara M; Katase S; Okada R; Morita E; Kawai S; Hamajima N; Wakai K
Urol Int; 2012; 89(1):39-44. PubMed ID: 22433834
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K;
Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749
[TBL] [Abstract][Full Text] [Related]
3. Kallikarein-related peptidase 3 common genetic variant and the risk of prostate cancer.
Motamedi RK; Sarhangi N; Afshari M; Sattari M; Jamaldini SH; Samzadeh M; Mohsen Ziaei SA; Pourmand GR; Hasanzad M
J Cell Biochem; 2019 Sep; 120(9):14822-14830. PubMed ID: 31017705
[TBL] [Abstract][Full Text] [Related]
4. Association between three genetic variants in kallikrein 3 and prostate cancer risk.
Ding WH; Ren KW; Yue C; Zou JG; Zuo L; Zhang LF; Bai Y; Okada A; Yasui T; Mi YY
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413614
[TBL] [Abstract][Full Text] [Related]
5. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
Beikzadeh B; Angaji SA; Abolhasani M
BMC Med Genet; 2020 Apr; 21(1):81. PubMed ID: 32295536
[TBL] [Abstract][Full Text] [Related]
6. DPP4 genetic variants influence baseline prostate-specific antigen levels: the J-MICC study.
Higashibata T; Naito M; Mori A; Ozawa N; Furuta M; Tsuchiya R; Koyama E; Morita E; Kawai S; Okada R; Yin G; Wakai K; Hamajima N
Nagoya J Med Sci; 2013 Feb; 75(1-2):73-80. PubMed ID: 23544270
[TBL] [Abstract][Full Text] [Related]
7. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.
He Y; Gu J; Strom S; Logothetis CJ; Kim J; Wu X
Clin Cancer Res; 2014 Oct; 20(19):5133-5139. PubMed ID: 25274378
[TBL] [Abstract][Full Text] [Related]
8. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.
Penney KL; Schumacher FR; Kraft P; Mucci LA; Sesso HD; Ma J; Niu Y; Cheong JK; Hunter DJ; Stampfer MJ; Hsu SI
Carcinogenesis; 2011 Jun; 32(6):853-9. PubMed ID: 21421545
[TBL] [Abstract][Full Text] [Related]
9. Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.
Parikh H; Wang Z; Pettigrew KA; Jia J; Daugherty S; Yeager M; Jacobs KB; Hutchinson A; Burdett L; Cullen M; Qi L; Boland J; Collins I; Albert TJ; Vatten LJ; Hveem K; Njølstad I; Cancel-Tassin G; Cussenot O; Valeri A; Virtamo J; Thun MJ; Feigelson HS; Diver WR; Chatterjee N; Thomas G; Albanes D; Chanock SJ; Hunter DJ; Hoover R; Hayes RB; Berndt SI; Sampson J; Amundadottir L
Hum Genet; 2011 Jun; 129(6):675-85. PubMed ID: 21318478
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein 3 and vitamin D receptor polymorphisms: potentials environmental risk factors for prostate cancer.
Hu J; Qiu Z; Zhang L; Cui F
Diagn Pathol; 2014 Apr; 9():84. PubMed ID: 24755043
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJ.
Menezes RDS; Dornas MC; Campos CFF; Rodeiro DB; Carrerette FB; Oliveira RV; de Souza BA; Alves de Souza Carvalho G; Brito IAA; Silva DA; Damião R; Porto LC
Prostate; 2024 Feb; 84(2):166-176. PubMed ID: 37839045
[TBL] [Abstract][Full Text] [Related]
12. Association of gene polymorphisms of KLK3 and prostate cancer: A meta-analysis.
Li H; Fei X; Shen Y; Wu Z
Adv Clin Exp Med; 2020 Aug; 29(8):1001-1009. PubMed ID: 32869960
[TBL] [Abstract][Full Text] [Related]
13. Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer.
Klein RJ; Halldén C; Cronin AM; Ploner A; Wiklund F; Bjartell AS; Stattin P; Xu J; Scardino PT; Offit K; Vickers AJ; Grönberg H; Lilja H
Cancer Prev Res (Phila); 2010 May; 3(5):611-9. PubMed ID: 20424135
[TBL] [Abstract][Full Text] [Related]
14. Single-nucleotide polymorphism rs1058205 of KLK3 is associated with the risk of prostate cancer: A case-control study of Han Chinese men in Northeast China.
Chen C; Xin Z
Medicine (Baltimore); 2017 Mar; 96(10):e6280. PubMed ID: 28272245
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men.
Sävblom C; Halldén C; Cronin AM; Säll T; Savage C; Vertosick EA; Klein RJ; Giwercman A; Lilja H
Clin Chem; 2014 Mar; 60(3):490-9. PubMed ID: 24270797
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population.
Sun J; Tao S; Gao Y; Peng T; Tan A; Zhang H; Yang X; Qin X; Hu Y; Feng J; Kim ST; Lin X; Wu Y; Zhang J; Li Z; Li L; Mo L; Liang Z; Shi D; Huang Z; Huang X; Liu M; Liu Q; Zhang S; Lilly Zheng S; Xu J; Mo Z
Hum Genet; 2013 Apr; 132(4):423-9. PubMed ID: 23269536
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of the combined evaluation of KLK3 genetics and free-to-total prostate specific antigen ratio for prostate cancer diagnosis.
Zambon CF; Prayer-Galetti T; Basso D; Padoan A; Rossi E; Secco S; Pelloso M; Fogar P; Navaglia F; Moz S; Zattoni F; Plebani M
J Urol; 2012 Oct; 188(4):1124-30. PubMed ID: 22901566
[TBL] [Abstract][Full Text] [Related]
18. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
[TBL] [Abstract][Full Text] [Related]
19. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
[TBL] [Abstract][Full Text] [Related]
20. Very low PSA concentrations and deletions of the KLK3 gene.
Rodriguez S; Al-Ghamdi OA; Burrows K; Guthrie PA; Lane JA; Davis M; Marsden G; Alharbi KK; Cox A; Hamdy FC; Neal DE; Donovan JL; Day IN
Clin Chem; 2013 Jan; 59(1):234-44. PubMed ID: 23169475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
